Novadip Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 48
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $11.4M
Latest Deal Amount
  • Investors
  • 11

Novadip General Information

Description

Developer of cell-based regeneration therapies designed to offer new generation treatment. The company's therapies provides assistance to treat bone defects and bone diseases, hard and soft tissue reconstruction from autologous adipose stem cells, enabling doctors and patients to get more positive clinical outcomes and long-term quality of life.

Contact Information

Website
www.novadip.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
  • Watson & Crick Hill
  • Rue Granbonpré 11
  • 1435 Mont-Saint-Guibert
  • Belgium
+32 010 00 00 00

Novadip Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novadip Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 23-Dec-2020 $11.4M 000.00 Completed Generating Revenue
5. Later Stage VC 28-Jan-2019 00.00 000.00 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 10-Sep-2015 000.00 000.00 Completed Generating Revenue
3. Grant 01-Jan-2015 00.000 000.00 Completed Generating Revenue
2. Early Stage VC 20-Feb-2014 $11.6M $11.6M Completed Generating Revenue
1. Grant 01-Jan-2013 $722K Completed Startup
To view Novadip’s complete valuation and funding history, request access »

Novadip Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Category A2 00,000 000.000000 000.0 000.0 00 000.0 00.00
Class A1 000,000 000.000000 000.00 000.00 00 000.00 00.000
Pref 30,000 $11.412911 $11.41 $11.41 1x $11.41 5.76%
To view Novadip’s complete cap table history, request access »

Novadip Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cell-based regeneration therapies designed to offer new generation treatment. The company's therapies provi
Biotechnology
Mont-Saint-Guibert, Belgium
48 As of 2021
000.00
0000000000 000.00

0000000

co laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt
0000000000000
New York, NY
00 As of 0000
000.00
0000000000 0 000.00

00000000

nim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000000
Mont-Saint-Guibert, Belgium
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novadip Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EpiBone Venture Capital-Backed New York, NY 00 000.00 0000000000 0 000.00
0000000000 0000000 Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 00000 00000000000 00000
000000 0000 Formerly VC-backed Jerusalem, Israel 000 00000 00000000 00000
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000 000000000 Venture Capital-Backed South San Francisco, CA 00 00000 000000000000 00000
You’re viewing 5 of 16 competitors. Get the full list »

Novadip Executive Team (6)

Name Title Board Seat Contact Info
Denis Dufrane Ph.D Co-Founder, Chief Executive Officer, Board Member & Chief Scientific Officer
Virginie Cartage Chief Financial Officer
Nicolas Theys Ph.D Chief Technology Officer
Roland Gordon-Beresford Chief Regulatory Affairs and Intellectual Property Officer
You’re viewing 4 of 6 executive team members. Get the full list »

Novadip Board Members (9)

Name Representing Role Since
Cédric Sacré Self Board Member 000 0000
Christina Franssen Ph.D Société Régionale d'Investissement de Wallonie Board Member 000 0000
Eric Pâques Ph.D Self Chairman 000 0000
Gil Beyen Self Board Member 000 0000
Jean-Pierre Bizet Ph.D New Science Ventures Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Novadip Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novadip Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Investsud Venture Capital Minority 000 0000 000000 0
Epimède Venture Capital Minority 000 0000 000000 0
Federal Holding and Investment Company Holding Company Minority 000 0000 000000 0
Fund+ Venture Capital Minority 000 0000 000000 0
Intégrale Corporation Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »